BIODESIX INC
For the period ended May 19, 2026. Filed Apr 9, 2026.
View on SEC.govAbout this filing
What shareholders are asked to vote on at a company's meeting. It is where to find what directors and top executives are paid, and who owns the most shares.
May 19, 2026 · Filed Apr 9, 2026
Contents
Cover page
Show cover page
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, DC 20549
SCHEDULE 14A
(Rule
14a-101)
SCHEDULE 14A INFORMATION
Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934
(Amendment No.
)
| ☒ | Filed by the Registrant |
|---|---|
| ☐ | Filed by a Party other than the Registrant |
Check the appropriate box:
| ☐ | Preliminary Proxy Statement |
|---|---|
| ☐ | Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2)) |
| ☒ | Definitive Proxy Statement |
| ☐ | Definitive Additional Materials |
| ☐ | Soliciting Material under § 240.14a-12 |
Biodesix, Inc.
(Name of Registrant as Specified in its Charter)
(Name of Person(s) Filing Proxy Statement, if Other Than the Registrant)
Payment of Filing Fee (Check the appropriate box):
| ☒ | No fee required. |
|---|---|
| ☐ | Fee paid previously with preliminary materials. |
| ☐ | Fee computed on table in exhibit required by Item 25(b) per Exchange Act Rules 14a-6(i)(1) and 0-11. |
Biodesix, Inc.
919 West Dillon Rd.,
Louisville, CO 80027
Notice of 2026 Annual Meeting of Stockholders
Dear Biodesix Stockholders:
You are invited to attend Biodesix, Inc.’s 2026 Annual Meeting of Stockholders (the Annual Meeting).
| Date: | May 19, 2026 (Tuesday) |
|---|---|
| Time: | 1:00 p.m., Mountain Time |
| Virtual Location: | You can attend the Annual Meeting online, including to vote and/or submit questions, at www.proxydocs.com/BDSX. See page 1 of the accompanying proxy statement for additional information regarding participation in the virtual meeting. |
| Items of Business: | At the Annual Meeting, stockholders will be asked to vote: 1. To elect the two Class III directors named in this proxy statement to hold office until the 2029 annual meeting of stockholders; 2. To hold a non-binding advisory vote to approve the compensation of our named executive officers, as described in the accompanying proxy statement; 3. To hold a non-binding advisory vote on the frequency of solicitation of advisory votes to approve named executive officer compensation; and 4. To ratify the appointment of KPMG LLP as our independent registered public accounting firm for the year ending December 31, 2026. In addition, we will conduct any other business properly brought before the meeting, or any adjournment or postponement thereof. |
| Record Date: | You can participate in the Annual Meeting and vote if you were a stockholder of record as of the close of business on March 23, 2026. |
| Voting: | Your vote is very important to us. Whether or not you plan to attend the virtual Annual Meeting, please ensure your shares are represented by voting promptly. For instructions on how to vote your shares, please refer to the Internet Notice, the section entitled “Annual Meeting Information” beginning on page 1 of the accompanying proxy statement or, if you requested to receive printed copies of these materials, your enclosed proxy card. |
By order of the Board of Directors,
Robin Harper Cowie
Chief Financial Officer, Secretary and Treasurer
April 9, 2026
Important Notice Regarding the Internet Availability of Proxy Materials for the Annual Meeting to be Held on May 19, 2026 at 1:00 p.m. Mountain Time via live audio webcast at www.proxydocs.com/BDSX
This Notice of 2026 Annual Meeting of Stockholders, the accompanying proxy statement and our 2025 Annual Report on Form 10-K are available on our website at https://investors.biodesix.com/investor-relations in the SEC Filings section, as well as atwww.proxydocs.com/BDSX.
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.